News

Nuix hires ex-Juniper exec Lori Cornmesser to run partner ecosystems

SYDNEY — November 12, 2026 -- Nuix (ASX: NXL) has appointed Lori Cornmesser as Global Vice President, Partner Ecosystems, reporting directly to Chief Customer Officer Oliver Harvey. Cornmesser previously managed more than 5,000 global alliance partners at Juniper; Nuix did not disclose how many partners it has today.

Her remit covers six partner types: global systems integrators, service providers, cloud marketplaces, channel partners, resellers and technology ecosystems. She will oversee partner engagement, enablement and joint go-to-market execution.

The reporting line places the partner function under the customer organization led by Harvey. Harvey says Cornmesser has a track record of turning partner programs into primary growth engines.

Thryv Therapeutics closes $30M Series B before UBS conference talk

Image
Thryv Therapeutics closes $30M Series B before UBS conference talk

SAN FRANCISCO -- November 12, 2026 -- Thryv Therapeutics closed a $30 million Series B financing led by InClin, Inc., and Chairman and CEO Paul Truex will present the company's SGK1 inhibitor pipeline at the UBS Global Biopharma Conference in London. Existing investors also took part in the round, according to the company.

The fireside chat is scheduled for Tuesday, November 17, 2026, at 3:20 pm GMT (10:20 am ET), on the second day of the November 16-17 conference. Thryv will also hold one-on-one investor meetings. The talk comes before the first efficacy data from the company's lead candidate, THRV-1268, which the company expects in early 2027.

Thryv has completed enrollment in the first efficacy cohort of Wave II, a Phase 2/3 study (NCT07277582) of THRV-1268 in patients with Long QT Syndrome Type 2 and Type 3. Both the Wave II readout and the opening of enrollment in the company's second trial fall in early 2027.

THINK Surgical wins 2026 AAHKS award for TMINI robot

Image
THINK Surgical wins 2026 AAHKS award for TMINI robot

DALLAS – November 11, 2026 -- THINK Surgical received the 2026 AAHKS Industry Innovation Award for its TMINI Miniature Robotic System at the society's annual meeting in Dallas. The company's submission rests on a regulatory step it took 324 days before the Nov. 11, 2026 release: FDA 510(k) clearance, dated Dec. 22, 2025, for using TMINI with Stryker's Triathlon Total Knee System.

THINK Surgical says it developed the Triathlon compatibility without Stryker

According to THINK Surgical, it developed the compatibility independently, without partnership or collaboration with Stryker Corporation or any of its affiliates. The company describes the clearance as a major step in returning implant choice to surgeons and healthcare facilities. It also says TMINI has shown both a technical and a regulatory pathway to a fully open platform. Those are the company's characterizations, not findings by the FDA or AAHKS.

Sempra declares $0.6575 quarterly dividend payable Jan. 15, 2027

Image
Sempra declares $0.6575 quarterly dividend payable Jan. 15, 2027

SAN DIEGO -- November 11, 2026 -- Sempra (NYSE: SRE) has declared a quarterly dividend of $0.6575 per share on its common stock, payable Jan. 15, 2027. Annualized, the rate works out to $2.63 per share (4 x $0.6575), by FairsOnline's calculation.

Only common stock shareholders of record at the close of business on Dec. 10, 2026 will receive the payment. The release names no other share class.

The company did not disclose the prior quarterly rate, so the size and direction of any change cannot be determined from the release.

The record date falls 29 days after the Nov. 11 announcement. Payment follows 36 days after the record date, or 65 days after the announcement.

Implantica to report Q3 2026 results on November 19 at 08:00 CET

VADUZ – November 12, 2026 -- Implantica AG will publish its Q3 2026 interim report at 8:00 a.m. CET on November 19, one week after announcing the date on November 12. The company will present the results to investors at 15:00 CET the same day, which gives the market seven hours to read the report before management speaks.

The presentation will be held in English by webcast, with a separate teleconference. Webcast access is open by link. Teleconference participants must register first and will then receive a dial-in number and a conference ID.

Three executives will present the Q3 2026 results

CEO Peter Forsell, the CFO and Chief Corporate Affairs Officer Nicole Pehrsson are the announced speakers. Pehrsson is also the investor relations contact named in the release.

Implantica's shares trade on the Nasdaq First North Premier Growth Market in Stockholm under the ticker IMP A SDB. FNCA Sweden AB is the company's Certified Adviser.

Deloitte named Leader in IDC digital identity services ranking

Image
Deloitte named Leader in IDC digital identity services ranking

NEW YORK -- November 12, 2026 -- Deloitte is one of five vendors named a Leader in the inaugural IDC MarketScape: Worldwide Digital Identity Services 2026 Vendor Assessment (Doc #US53011526, October 2026). IDC evaluated 17 vendors, so five Leaders is about 29% of the field and 12 vendors fall outside the Leader group, by FairsOnline's calculation.

The assessment is the first edition, so there is no earlier IDC ranking against which to measure Deloitte's placement.

Eligible Inc earns four X12 Certification Seals for operating rules

Image
Eligible Inc earns four X12 Certification Seals for operating rules

NEW YORK – November 12, 2026 -- Eligible Inc has earned four X12 Certification Seals, covering Eligibility & Benefits, Claim Status, Payment & Remittance, and Health Care Claim Operating Rules, the company said. X12 granted the seals after third-party testing and an evaluation of Eligible's application.

Only one of the four areas carries a numeric requirement in the release. The eligibility seal covers coverage responses, including co-pays, coinsurance, deductibles and eligibility dates, returned in 20 seconds or less.

LifePath Paycheck links BlackRock target-date funds to annuities

Image
LifePath Paycheck links BlackRock target-date funds to annuities

WASHINGTON – November 12, 2026 -- The National Institute on Retirement Security (NIRS) released Episode 7 of its Retirement in America podcast, in which BlackRock's Nick Nefouse describes how LifePath Paycheck builds guaranteed lifetime income into a 401(k) target-date strategy. Nefouse is Global Head of Retirement Solutions and Head of LifePath at BlackRock. NIRS Executive Director Dan Doonan hosts the episode, titled "Making the 401(k) Look More Like a Pension: The Future of Lifetime Retirement Income."

LifePath Paycheck builds a group annuity allocation as participants near retirement

According to the release, the strategy gradually builds an allocation to group annuity contracts as participants approach retirement. Participants may elect to convert that allocation into a lifetime income stream. The rest of their savings stays invested and accessible.

AGNC declares $0.12 November dividend, payable December 9

BETHESDA -- November 12, 2026 -- AGNC Investment Corp. (Nasdaq: AGNC) declared a cash dividend of $0.12 per common share for November 2026, payable on December 9, 2026 to common stockholders of record as of November 30, 2026.

Held for 12 months, the monthly rate would total $1.44 per share, by FairsOnline's calculation. The release does not say whether the board has set any dividend beyond November.

The schedule is short. The record date falls 18 days after the November 12 announcement, and payment follows 9 days after the record date, 27 days after the announcement. Only holders on the register at the close of November 30 receive the payment.